DiogenX

Private

MarseilleHealthcare & Life Scienceshttps://diogenx.com/

Last Round

Series A

Extension

Oct 31, 2023

Total Funding Raised

$45.05M

Company Overview

DiogenX is a biotechnology company that develops innovative biologics and regenerative therapies for the treatment of type 1 diabetes.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

regenerative medicinetype 1 diabetesbeta cell regenerationrecombinant proteinbiotechWnt signalingdrug discoverydisease-modifying therapybeta cell therapypreclinical biotechinsulin independencebiopharma partnershiptherapeutic candidatediabetes cure research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DiogenX Comps

Public and private peers based on sector, stage, and business model.

DiogenX comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

DiogenX Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A Extension	Oct 31, 2023
Grant	Oct 1, 2023
Series A	May 10, 2023
Seed	Jun 16, 2020

View all Funding Rounds

DiogenX Investors

Notable investors and investment history

DiogenX investors
Investor	Rounds
European Innovation Council	Grant
Roche Venture Fund	Series A
Boehringer Ingelheim	Seed, Series A
Roche Venture Fund	Series A, Series A Extension
JDRF	Series A, Seed, Series A Extension
Boehringer Ingelheim Venture Fund	Seed, Series A, Series A Extension
Omnes Capital	Series A

View all Investors

DiogenX Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

DiogenX Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about DiogenX's valuation, stock price, and market status.

Firmographic Details

HeadquartersMarseille

Employee Range25

Year Founded2020

Last FundingOct 31, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.